European Journal of Dermatology
MENUDelayed skin toxicity associated with pembrolizumab therapy for metastatic melanoma Volume 29, issue 3, May-June 2019
Figures
1 Department of Dermatology, Churchill Hospital,
2 Cellular Pathology Department, John Radcliffe Hospital, Oxford, UK
- DOI : 10.1684/ejd.2019.3592
- Page(s) : 349-51
- Published in: 2019
An 81-year-old male presented to our department of dermatology in March 2019 with a six-week history of a pruritic rash initially affecting the back. The rash continued to extend involving the limbs despite treatment with topical emollients, topical moderately potent corticosteroids, and oral antihistamines. He had not started any new medications recently and was otherwise systemically well.Examination revealed a minimally scaly erythematous, indurated and granulomatous rash with follicular accentuation, [...]